Bausch Cash And Equivalents vs Short Term Debt Analysis

BHC Stock

USD 8.71 0.09 1.04%

Bausch Health financial indicator trend analysis is way more than just evaluating Bausch Health Companies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bausch Health Companies is a good investment. Please check the relationship between Bausch Health Cash And Equivalents and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Cash And Equivalents vs Short Term Debt

Cash And Equivalents vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bausch Health Companies Cash And Equivalents account and Short Term Debt. At this time, the significance of the direction appears to have strong relationship.

The correlation between Bausch Health's Cash And Equivalents and Short Term Debt is 0.72. Overlapping area represents the amount of variation of Cash And Equivalents that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Bausch Health Companies, assuming nothing else is changed. The correlation between historical values of Bausch Health's Cash And Equivalents and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Equivalents of Bausch Health Companies are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Cash And Equivalents i.e., Bausch Health's Cash And Equivalents and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.72

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Cash And Equivalents

Short Term Debt

Most indicators from Bausch Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

At present, Bausch Health's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.31, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.

	2021	2022	2023	2024 (projected)
Gross Profit	6.0B	5.8B	6.2B	6.5B
Total Revenue	8.4B	8.1B	8.8B	9.2B

Gross Profit Total Revenue

Bausch Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Inventory	Common Stock Total Equity	Short Term Investments
Total Assets		0.88	0.64	0.72	0.4	0.62	0.88	-0.2	0.33	0.31	0.99	0.47	0.31	0.86	0.74	0.93	0.54	-0.26	0.92	0.14	0.63	0.3	0.86	0.58	0.8	-0.15
Short Long Term Debt Total	0.88		0.63	0.89	0.05	0.85	1.0	-0.54	0.64	0.37	0.87	0.45	0.37	0.92	0.67	0.98	0.8	-0.38	0.98	0.47	0.73	0.37	0.66	0.83	0.85	0.2
Other Current Liab	0.64	0.63		0.63	-0.03	0.56	0.65	-0.42	0.19	0.05	0.63	0.36	0.05	0.53	0.56	0.65	0.42	-0.25	0.65	0.27	0.43	-0.02	0.4	0.38	0.6	0.05
Total Current Liabilities	0.72	0.89	0.63		-0.19	0.87	0.87	-0.7	0.71	0.58	0.67	0.2	0.57	0.76	0.63	0.82	0.83	-0.38	0.87	0.59	0.83	0.53	0.38	0.82	0.81	0.45
Total Stockholder Equity	0.4	0.05	-0.03	-0.19		-0.22	0.07	0.72	-0.38	-0.12	0.45	-0.03	-0.12	0.21	0.24	0.17	-0.29	0.19	0.11	-0.61	-0.15	-0.06	0.73	-0.21	0.01	-0.68
Property Plant And Equipment Net	0.62	0.85	0.56	0.87	-0.22		0.85	-0.78	0.86	0.28	0.58	0.21	0.28	0.85	0.65	0.78	0.89	-0.4	0.81	0.79	0.79	0.26	0.29	0.94	0.86	0.48
Net Debt	0.88	1.0	0.65	0.87	0.07	0.85		-0.52	0.63	0.29	0.88	0.46	0.29	0.93	0.67	0.99	0.8	-0.37	0.98	0.47	0.7	0.31	0.68	0.82	0.85	0.18
Retained Earnings	-0.2	-0.54	-0.42	-0.7	0.72	-0.78	-0.52		-0.79	-0.32	-0.14	-0.19	-0.32	-0.41	-0.43	-0.42	-0.73	0.25	-0.47	-0.88	-0.61	-0.24	0.22	-0.74	-0.64	-0.63
Accounts Payable	0.33	0.64	0.19	0.71	-0.38	0.86	0.63	-0.79		0.33	0.29	0.02	0.33	0.68	0.45	0.55	0.87	-0.33	0.59	0.87	0.69	0.45	0.07	0.94	0.66	0.52
Cash	0.31	0.37	0.05	0.58	-0.12	0.28	0.29	-0.32	0.33		0.25	0.04	1.0	0.22	0.32	0.29	0.24	-0.18	0.34	0.07	0.51	0.8	0.1	0.28	0.37	0.22
Non Current Assets Total	0.99	0.87	0.63	0.67	0.45	0.58	0.88	-0.14	0.29	0.25		0.46	0.25	0.85	0.72	0.92	0.51	-0.24	0.9	0.09	0.53	0.26	0.9	0.54	0.77	-0.18
Non Currrent Assets Other	0.47	0.45	0.36	0.2	-0.03	0.21	0.46	-0.19	0.02	0.04	0.46		0.04	0.4	0.24	0.53	0.19	-0.14	0.5	0.02	0.32	-0.17	0.4	0.21	0.3	-0.28
Cash And Short Term Investments	0.31	0.37	0.05	0.57	-0.12	0.28	0.29	-0.32	0.33	1.0	0.25	0.04		0.21	0.32	0.29	0.24	-0.18	0.34	0.06	0.51	0.8	0.1	0.28	0.37	0.22
Net Receivables	0.86	0.92	0.53	0.76	0.21	0.85	0.93	-0.41	0.68	0.22	0.85	0.4	0.21		0.66	0.94	0.77	-0.41	0.93	0.48	0.71	0.28	0.71	0.85	0.8	0.07
Common Stock Shares Outstanding	0.74	0.67	0.56	0.63	0.24	0.65	0.67	-0.43	0.45	0.32	0.72	0.24	0.32	0.66		0.66	0.5	0.08	0.66	0.32	0.53	0.21	0.52	0.56	0.91	-0.04
Non Current Liabilities Total	0.93	0.98	0.65	0.82	0.17	0.78	0.99	-0.42	0.55	0.29	0.92	0.53	0.29	0.94	0.66		0.74	-0.35	0.99	0.38	0.71	0.32	0.77	0.77	0.8	0.04
Other Current Assets	0.54	0.8	0.42	0.83	-0.29	0.89	0.8	-0.73	0.87	0.24	0.51	0.19	0.24	0.77	0.5	0.74		-0.28	0.77	0.75	0.73	0.34	0.26	0.93	0.73	0.56
Other Stockholder Equity	-0.26	-0.38	-0.25	-0.38	0.19	-0.4	-0.37	0.25	-0.33	-0.18	-0.24	-0.14	-0.18	-0.41	0.08	-0.35	-0.28		-0.36	-0.29	-0.34	-0.16	-0.09	-0.38	-0.2	-0.35
Total Liab	0.92	0.98	0.65	0.87	0.11	0.81	0.98	-0.47	0.59	0.34	0.9	0.5	0.34	0.93	0.66	0.99	0.77	-0.36		0.43	0.79	0.37	0.72	0.8	0.81	0.08
Property Plant And Equipment Gross	0.14	0.47	0.27	0.59	-0.61	0.79	0.47	-0.88	0.87	0.07	0.09	0.02	0.06	0.48	0.32	0.38	0.75	-0.29	0.43		0.59	0.16	-0.2	0.78	0.55	0.6
Total Current Assets	0.63	0.73	0.43	0.83	-0.15	0.79	0.7	-0.61	0.69	0.51	0.53	0.32	0.51	0.71	0.53	0.71	0.73	-0.34	0.79	0.59		0.47	0.32	0.8	0.67	0.24
Short Term Debt	0.3	0.37	-0.02	0.53	-0.06	0.26	0.31	-0.24	0.45	0.8	0.26	-0.17	0.8	0.28	0.21	0.32	0.34	-0.16	0.37	0.16	0.47		0.21	0.38	0.26	0.12
Intangible Assets	0.86	0.66	0.4	0.38	0.73	0.29	0.68	0.22	0.07	0.1	0.9	0.4	0.1	0.71	0.52	0.77	0.26	-0.09	0.72	-0.2	0.32	0.21		0.32	0.48	-0.5
Inventory	0.58	0.83	0.38	0.82	-0.21	0.94	0.82	-0.74	0.94	0.28	0.54	0.21	0.28	0.85	0.56	0.77	0.93	-0.38	0.8	0.78	0.8	0.38	0.32		0.78	0.4
Common Stock Total Equity	0.8	0.85	0.6	0.81	0.01	0.86	0.85	-0.64	0.66	0.37	0.77	0.3	0.37	0.8	0.91	0.8	0.73	-0.2	0.81	0.55	0.67	0.26	0.48	0.78		0.23
Short Term Investments	-0.15	0.2	0.05	0.45	-0.68	0.48	0.18	-0.63	0.52	0.22	-0.18	-0.28	0.22	0.07	-0.04	0.04	0.56	-0.35	0.08	0.6	0.24	0.12	-0.5	0.4	0.23

Click cells to compare fundamentals

Bausch Health Account Relationship Matchups

Bausch Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.9B	31.2B	29.2B	25.7B	27.4B	14.9B
Short Long Term Debt Total	25.9B	23.9B	22.7B	20.8B	22.4B	23.5B
Other Current Liab	2.1B	4.6B	4.8B	3.0B	1.0B	1.2B
Total Current Liabilities	6.2B	4.9B	5.2B	3.9B	4.3B	4.5B
Total Stockholder Equity	1.1B	535M	(106M)	(692M)	(1.0B)	(970.9M)
Property Plant And Equipment Net	1.5B	1.6B	1.6B	1.6B	1.7B	1.8B
Net Debt	22.7B	23.3B	22.1B	20.2B	21.4B	22.5B
Retained Earnings	(7.5B)	(8.0B)	(9.0B)	(9.2B)	(9.8B)	(9.3B)
Accounts Payable	503M	337M	407M	521M	719M	755.0M
Cash	3.2B	605M	582M	564M	947M	502.7M
Non Current Assets Total	26.9B	25.9B	23.6B	21.4B	21.8B	12.7B
Non Currrent Assets Other	411M	664M	340M	326M	307M	236.2M
Cash And Short Term Investments	3.2B	605M	582M	564M	947M	506.0M
Net Receivables	1.8B	1.6B	1.8B	1.8B	2.0B	2.1B
Common Stock Shares Outstanding	352.1M	355M	358.9M	362M	364.9M	246.3M
Liabilities And Stockholders Equity	33.9B	31.2B	29.2B	25.7B	27.4B	14.9B
Non Current Liabilities Total	26.5B	25.7B	24.0B	21.5B	23.1B	24.3B
Other Current Assets	779M	855M	720M	776M	1.1B	1.1B
Other Stockholder Equity	429M	454M	462M	159M	214M	203.3M
Total Liab	32.7B	30.6B	29.2B	25.4B	27.4B	28.8B
Property Plant And Equipment Gross	1.5B	1.6B	3.4B	3.5B	3.8B	4.0B
Total Current Assets	7.0B	5.3B	5.6B	4.2B	5.6B	5.9B
Accumulated Other Comprehensive Income	(2.1B)	(2.1B)	(1.9B)	(2.1B)	(1.9B)	(1.8B)
Short Term Debt	1.2B	52M	49.9M	432M	450M	472.5M
Intangible Assets	10.2B	8.4B	6.9B	5.8B	6.5B	5.8B
Inventory	1.1B	1.1B	993M	1.1B	1.5B	1.6B
Common Stock Total Equity	10.2B	10.2B	10.3B	10.4B	11.9B	7.0B
Common Stock	10.2B	10.2B	10.3B	10.4B	10.4B	6.1B
Other Liab	1.6B	1.5B	1.2B	967M	1.1B	1.3B
Current Deferred Revenue	2.4B	(52M)	(49.9M)	2.1B	2.4B	2.5B
Other Assets	1.8B	2.8B	2.3B	2.3B	2.6B	2.7B
Long Term Debt	24.7B	23.9B	22.7B	20.3B	21.9B	14.0B
Good Will	13.1B	13.0B	12.5B	11.5B	11.2B	7.2B
Property Plant Equipment	1.5B	1.6B	1.6B	1.8B	2.1B	2.2B
Net Tangible Assets	(22.3B)	(21.0B)	(19.5B)	(18.0B)	(16.2B)	(17.0B)
Noncontrolling Interest In Consolidated Entity	73M	70M	72M	952M	1.1B	1.1B
Retained Earnings Total Equity	(7.5B)	(8.0B)	(9.0B)	(9.2B)	(8.3B)	(7.9B)
Long Term Debt Total	24.7B	23.9B	22.7B	20.3B	23.4B	21.5B

Bausch Health Investors Sentiment

The influence of Bausch Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bausch. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Bausch Health's public news can be used to forecast risks associated with an investment in Bausch. The trend in average sentiment can be used to explain how an investor holding Bausch can time the market purely based on public headlines and social activities around Bausch Health Companies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Bausch Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bausch Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bausch Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bausch Health.

Bausch Health Implied Volatility

67.82

Bausch Health's implied volatility exposes the market's sentiment of Bausch Health Companies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bausch Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bausch Health stock will not fluctuate a lot when Bausch Health's options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bausch Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bausch Health's short interest history, or implied volatility extrapolated from Bausch Health options trading.

Pair Trading with Bausch Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bausch Stock

0.74	A	Agilent Technologies Financial Report 28th of May 2024	Pair Corr
0.8	ELEV	Elevation Oncology Earnings Call This Week	Pair Corr
0.71	FHTX	Foghorn TherapeuticsInc Financial Report 13th of May 2024	Pair Corr

Moving against Bausch Stock

0.53

MOLN

Molecular Partners Financial Report 10th of May 2024

Pair Corr

The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.

The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:

How To Invest In Bausch

Details

Is Bausch Stock a good investment?

Details

What is Bausch Health's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Bausch Stock analysis

When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.

	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes

Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.115

Earnings Share

(1.62)

Revenue Per Share

23.998

Quarterly Revenue Growth

0.098

Return On Assets

0.0382

The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bausch Cash And Equivalents vs Short Term Debt Analysis

Cash And Equivalents vs Short Term Debt

Cash And Equivalents vs Short Term Debt Correlation Analysis

Correlation Coefficient

Cash And Equivalents

Short Term Debt

Bausch Health fundamental ratios Correlations

Bausch Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bausch Health fundamental ratios Accounts

Bausch Health Investors Sentiment

Bausch Health Implied Volatility

Pair Trading with Bausch Health

Moving together with Bausch Stock

Moving against Bausch Stock

Complementary Tools for Bausch Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total

Property Plant And Equipment Gross	- 0.88	Retained Earnings
Accounts Payable	- 0.79	Retained Earnings
Retained Earnings	- 0.78	Property Plant And Equipment Net
Inventory	- 0.74	Retained Earnings
Other Current Assets	- 0.73	Retained Earnings
Retained Earnings	- 0.7	Total Current Liabilities